File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Global Health System Resilience during Encounters with Stressors – Lessons Learnt from Cancer Services during the COVID-19 Pandemic

TitleGlobal Health System Resilience during Encounters with Stressors – Lessons Learnt from Cancer Services during the COVID-19 Pandemic
Authors
KeywordsCancer
COVID-19
health policy
health systems
resilience
Issue Date23-Apr-2023
PublisherElsevier
Citation
Clinical Oncology, 2023, v. 35, n. 4, p. e289-e300 How to Cite?
Abstract

Aims

The protracted COVID-19 pandemic has overwhelmed health systems globally, including many aspects of cancer control. This has underscored the multidimensional nature of cancer control, which requires a more comprehensive approach involving taking a wider perspective of health systems. Here, we investigated aspects of health system resilience in maintaining cancer services globally during the COVID-19 pandemic. This will allow for health systems to be resilient to different types of system stressors/shocks in the future, to allow cancer care to be maintained optimally.

Materials and methods

Using the World Health Organization health system framework (capturing aspects of service delivery, health workforce, information, medical products, vaccines and technologies, financing and governance and leadership), we carried out a comparative analysis of the impact of COVID-19 and the synthesis of the findings in responses in cancer care in 10 countries/jurisdictions across four continents comprising a wide diversity of health systems, geographical regions and socioeconomic status (China, Colombia, Egypt, Hong Kong SAR, Indonesia, India, Singapore, Sri Lanka, UK and Zambia). A combination of literature and document reviews and interviews with experts was used.

Results

Our study revealed that: (i) underlying weaknesses of health systems before the pandemic were exacerbated by the pandemic (e.g. economic issues in low- and middle-income countries led to greater shortage of medication and resource constraints compounded by inadequacies of public financing and issues of engagement with stakeholders and leadership/governance); (ii) no universal adaptive strategies were applicable to all the systems, highlighting the need for health systems to design emergency plans based on local context; (iii) despite the many differences between health systems, common issues were identified, such as the lack of contingency plan for pandemics, inadequate financial policies for cancer patients and lack of evidence-based approaches for competing priorities of cancer care/pandemic control.

Conclusion

We identified four key points/recommendations to enhance the resilient capacity of cancer care during the COVID-19 pandemic and other system stressors: (i) effective pandemic control approaches in general are essential to maintain the continuity of cancer care during the emergency health crises; (ii) strong health systems (with sufficient cancer care resources, e.g. health workforce, and universal health coverage) are fundamental to maintain quality care; (iii) the ability to develop response strategies and adapt to evolving evidence/circumstances is critical for health system resilience (including introducing systematic, consistent and evidence-based changes, national support and guidance in policy development and implementation); (iv) preparedness and contingency plans for future public health emergencies, engaging the whole of society, to achieve health system resilience for future crises and to transform healthcare delivery beyond the pandemic.


Persistent Identifierhttp://hdl.handle.net/10722/342851
ISSN
2023 Impact Factor: 3.2
2023 SCImago Journal Rankings: 0.907

 

DC FieldValueLanguage
dc.contributor.authorYeoh, K-
dc.contributor.authorWu, Y-
dc.contributor.authorChakraborty, S-
dc.contributor.authorElhusseiny, G-
dc.contributor.authorGondhowiardjo, S-
dc.contributor.authorJoseph, N-
dc.contributor.authorLee, AWM-
dc.contributor.authorLoong, HH-
dc.contributor.authorMsadabwe-Chikuni, SC-
dc.contributor.authorTan, BF-
dc.contributor.authorOspina, AV-
dc.contributor.authorRoques, T-
dc.contributor.authorShum, HM-
dc.contributor.authorYeoh, EK-
dc.date.accessioned2024-05-02T03:06:21Z-
dc.date.available2024-05-02T03:06:21Z-
dc.date.issued2023-04-23-
dc.identifier.citationClinical Oncology, 2023, v. 35, n. 4, p. e289-e300-
dc.identifier.issn0936-6555-
dc.identifier.urihttp://hdl.handle.net/10722/342851-
dc.description.abstract<h3>Aims</h3><p>The protracted COVID-19 pandemic has overwhelmed health systems globally, including many aspects of cancer control. This has underscored the multidimensional nature of cancer control, which requires a more comprehensive approach involving taking a wider perspective of health systems. Here, we investigated aspects of health system resilience in maintaining cancer services globally during the COVID-19 pandemic. This will allow for health systems to be resilient to different types of system stressors/shocks in the future, to allow cancer care to be maintained optimally.</p><h3>Materials and methods</h3><p>Using the World Health Organization health system framework (capturing aspects of service delivery, health workforce, information, medical products, vaccines and technologies, financing and governance and leadership), we carried out a comparative analysis of the impact of COVID-19 and the synthesis of the findings in responses in cancer care in 10 countries/jurisdictions across four continents comprising a wide diversity of health systems, geographical regions and socioeconomic status (China, Colombia, Egypt, Hong Kong SAR, Indonesia, India, Singapore, Sri Lanka, UK and Zambia). A combination of literature and document reviews and interviews with experts was used.</p><h3>Results</h3><p>Our study revealed that: (i) underlying weaknesses of health systems before the pandemic were exacerbated by the pandemic (e.g. economic issues in low- and middle-income countries led to greater shortage of medication and resource constraints compounded by inadequacies of public financing and issues of engagement with stakeholders and leadership/governance); (ii) no universal adaptive strategies were applicable to all the systems, highlighting the need for health systems to design emergency plans based on local context; (iii) despite the many differences between health systems, common issues were identified, such as the lack of contingency plan for pandemics, inadequate financial policies for cancer patients and lack of evidence-based approaches for competing priorities of cancer care/pandemic control.</p><h3>Conclusion</h3><p>We identified four key points/recommendations to enhance the resilient capacity of cancer care during the COVID-19 pandemic and other system stressors: (i) effective pandemic control approaches in general are essential to maintain the continuity of cancer care during the emergency health crises; (ii) strong health systems (with sufficient cancer care resources, e.g. health workforce, and universal health coverage) are fundamental to maintain quality care; (iii) the ability to develop response strategies and adapt to evolving evidence/circumstances is critical for health system resilience (including introducing systematic, consistent and evidence-based changes, national support and guidance in policy development and implementation); (iv) preparedness and contingency plans for future public health emergencies, engaging the whole of society, to achieve health system resilience for future crises and to transform healthcare delivery beyond the pandemic.</p>-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofClinical Oncology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectCancer-
dc.subjectCOVID-19-
dc.subjecthealth policy-
dc.subjecthealth systems-
dc.subjectresilience-
dc.titleGlobal Health System Resilience during Encounters with Stressors – Lessons Learnt from Cancer Services during the COVID-19 Pandemic-
dc.typeArticle-
dc.identifier.doi10.1016/j.clon.2023.01.004-
dc.identifier.scopuseid_2-s2.0-85148716165-
dc.identifier.volume35-
dc.identifier.issue4-
dc.identifier.spagee289-
dc.identifier.epagee300-
dc.identifier.eissn1433-2981-
dc.identifier.issnl0936-6555-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats